Thomas Di Stefano
@Fiera Capital Corp
Latest period2024 - Q3ReportedManaged Assets$33.251BTotal holdings456
Assets growth rate4.04%Assets growth rate (2-Q avg)-1.4%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Fiera Capital Corp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 456 positions.
Assets under management
The assets under management (AUM) of Fiera Capital Corp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 33.251B in assets, with a quarterly growth rate of 4.04% and a 2-quarter average growth rate of -1.4%. The portfolio is managed by Thomas Di Stefano, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EWEdwards Lifesciences Corp
| 0% | $110.145M 1.192M shares@ $92.38 avg price | Exited |
CRBGCorebridge Finl Inc
| 0% | $52.496M 1.803M shares@ $29.12 avg price | Exited |
BMRNBiomarin Pharmaceutical Inc
| 0% | $51.288M 622,953 shares@ $82.33 avg price | Exited |
LADLithia Mtrs Inc
| 0% | $48.444M 191,894 shares@ $252.45 avg price | Exited |
PHMPulte Group Inc
| 0% | $40.71M 369,759 shares@ $110.11 avg price | Exited |
ATRCAtricure Inc
| 0% | $20.908M 918,207 shares@ $22.78 avg price | Exited |
VCYTVeracyte Inc
| 0% | $13.555M 625,536 shares@ $21.67 avg price | Exited |
DXCMDexcom Inc
| 0% | $6.881M 60,687 shares@ $113.38 avg price | Exited |
RRXRegal Rexnord Corporation
| 0% | $6.764M 50,019 shares@ $135.22 avg price | Exited |
EYPTEyepoint Pharmaceuticals Inc
| 0% | $5.89M 677,038 shares@ $8.7 avg price | Exited |